GT Biopharma Inc (GTBP) — Cash Flow Quality Index
GT Biopharma Inc (GTBP) has a Cash Flow Quality Index of -0.69x as of June 2016. Operating cash flow of $-1.06 Million is below net income of $1.54 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore GTBP asset base for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
GT Biopharma Inc Cash Flow Quality Index (1987–2016)
Historical Cash Flow Quality Index for GT Biopharma Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check GT Biopharma Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for GT Biopharma Inc (1987–2016)
Year-by-year earnings quality comparison for GT Biopharma Inc. For live market cap and the full company financial profile, see market value of GT Biopharma Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2016 | -0.09x | $-1.93 Million | $21.03 Million | ▲ +90.5% |
| 2007 | -0.96x | $-270.00K | $280.00K | ▼ -196.4% |
| 1990 | 1.00x | $900.00K | $900.00K | ▲ +0.0% |
| 1989 | 1.00x | $700.00K | $700.00K | ▲ +0.0% |
| 1988 | 1.00x | $100.00K | $100.00K | ▲ +500.0% |
| 1987 | 0.17x | $50.00K | $300.00K | — |